Breast Nodule Smart Manager · Assessment, Follow-up & Treatment Decision — free guideline decision tool
This tool maps the BI-RADS category to malignancy probability and follow-up/biopsy triage, then after diagnosis gives surgery, axillary management, and subtype-based systemic and radiotherapy principles.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Breast Nodule Smart Manager · Assessment, Follow-up & Treatment Decision do?
Use to triage imaging findings (1–2 routine, 3 short-term follow-up, 4–5 biopsy, 6 diagnosed) and, once a subtype is known, to outline treatment principles.
How is the result calculated?
BI-RADS category → malignancy probability and biopsy decision. Diagnosed → breast-conserving + RT vs mastectomy, SLNB (Z0011/AMAROS) vs dissection, and subtype-driven systemic therapy (endocrine/anti-HER2/chemo ± immunotherapy).
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Breast Nodule Smart Manager · Assessment, Follow-up & Treatment Decision now
This tool maps the BI-RADS category to malignancy probability and follow-up/biopsy triage, then after diagnosis gives surgery, axillary management, and subtype-based systemic and radiotherapy principles.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.